A new treatment for chronic wounds, developed by Crawford Healthcare and the University of Manchester, could save the NHS over £125m a year in the fight against antibiotic resistance, following the success of a breakthrough study.
With more than 5,000 major limb amputations taking place each year in England, at a cost of c£25,000 an operation, Crawford’s new silver-based wound dressing KerraContact Ag – developed in partnership with the University of Manchester – has prevented a near certain leg amputation at an NHS hospital following the failure of traditional antibiotic treatment.…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
